{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:54Z","timestamp":1786980114836,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00405-024-08888-3","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T16:34:13Z","timestamp":1723048453000},"page":"6397-6404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cystic fibrosis-related chronic rhinosinusitis: the key role of a comprehensive evaluation in the era of highly effective modulator therapy"],"prefix":"10.1007","volume":"281","author":[{"given":"Alberto","family":"Minzoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mazzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2372-2407","authenticated-orcid":false,"given":"Pietro","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Licci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Taccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bresci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giandomenico","family":"Maggiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"8888_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jcf.2008.03.007","volume":"7","author":"PM Farrell","year":"2008","unstructured":"Farrell PM (2008) The prevalence of cystic fibrosis in the European Union. J Cyst Fibros off J Eur Cyst Fibros Soc 7:450\u2013453","journal-title":"J Cyst Fibros off J Eur Cyst Fibros Soc"},{"key":"8888_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jcf.2008.03.009","volume":"7","author":"C Castellani","year":"2008","unstructured":"Castellani C et al (2008) Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros off J Eur Cyst Fibros Soc 7:179\u2013196","journal-title":"J Cyst Fibros off J Eur Cyst Fibros Soc"},{"key":"8888_CR3","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","volume":"388","author":"JS Elborn","year":"2016","unstructured":"Elborn JS (2016) Cystic fibrosis. Lancet Lond Engl 388:2519\u20132531","journal-title":"Lancet Lond Engl"},{"key":"8888_CR4","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1056\/NEJMra2216474","volume":"389","author":"H Grasemann","year":"2023","unstructured":"Grasemann H, Ratjen F, Cystic Fibrosis (2023) N Engl J Med 389:1693\u20131707","journal-title":"N Engl J Med"},{"key":"8888_CR5","first-page":"32","volume":"7","author":"C Safi","year":"2019","unstructured":"Safi C, Zheng Z, Dimango E, Keating C, Gudis DA (2019) Chronic rhinosinusitis in cystic fibrosis: diagnosis and Medical Management. Med Sci Basel Switz 7:32","journal-title":"Med Sci Basel Switz"},{"key":"8888_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF02914539","volume":"9","author":"VV King","year":"1991","unstructured":"King VV (1991) Upper respiratory disease, sinusitis, and polyposis. Clin Rev Allergy 9:143\u2013157","journal-title":"Clin Rev Allergy"},{"key":"8888_CR7","first-page":"1","volume":"279","author":"J Krajewska","year":"2022","unstructured":"Krajewska J, Zub K, S\u0142owikowski A, Zato\u0144ski T (2022) Chronic rhinosinusitis in cystic fibrosis: a review of therapeutic options. Eur. Arch. Oto-Rhino-Laryngol. Off. J. Eur. Fed. Oto-Rhino-Laryngol. Soc. EUFOS Affil. Ger. Soc. Oto-Rhino-Laryngol. - Head Neck Surg 279:1\u201324","journal-title":"- Head Neck Surg"},{"key":"8888_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2023.08.009","author":"RG Stone","year":"2023","unstructured":"Stone RG, Short C, Davies JC, McNally P (2023) Chronic rhinosinusitis in the era of CFTR modulator therapy. J Cyst Fibros off J Eur Cyst Fibros Soc. S1569\u20131993(23)00877\u20139 https:\/\/doi.org\/10.1016\/j.jcf.2023.08.009","journal-title":"J Cyst Fibros off J Eur Cyst Fibros Soc"},{"key":"8888_CR9","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","volume":"365","author":"BW Ramsey","year":"2011","unstructured":"Ramsey BW et al (2011) A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 365:1663\u20131672","journal-title":"N Engl J Med"},{"key":"8888_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/1945892420912368","volume":"34","author":"SE Lee","year":"2020","unstructured":"Lee SE et al (2020) Cystic fibrosis transmembrane Conductance Regulator Modulator Therapy: a review for the otolaryngologist. Am J Rhinol Allergy 34:573\u2013580","journal-title":"Am J Rhinol Allergy"},{"key":"8888_CR11","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","volume":"381","author":"PG Middleton","year":"2019","unstructured":"Middleton PG et al (2019) Elexacaftor-Tezacaftor-Ivacaftor for cystic fibrosis with a single Phe508del allele. N Engl J Med 381:1809\u20131819","journal-title":"N Engl J Med"},{"key":"8888_CR12","first-page":"554","volume":"10","author":"N Kapouni","year":"2023","unstructured":"Kapouni N, Moustaki M, Douros K, Loukou I (2023) Efficacy and safety of Elexacaftor-Tezacaftor-Ivacaftor in the treatment of cystic fibrosis: a systematic review. Child Basel Switz 10:554","journal-title":"Child Basel Switz"},{"key":"8888_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4193\/Rhin20.601","volume":"58","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens WJ et al (2020) Executive summary of EPOS 2020 including integrated care pathways. Rhinology 58:82\u2013111","journal-title":"Rhinology"},{"key":"8888_CR14","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/lary.29766","volume":"132","author":"AH Khan","year":"2022","unstructured":"Khan AH et al (2022) Development of Sinonasal Outcome Test (SNOT\u201322) domains in chronic Rhinosinusitis with nasal polyps. Laryngoscope 132:933\u2013941","journal-title":"Laryngoscope"},{"key":"8888_CR15","doi-asserted-by":"publisher","unstructured":"Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, Adinoff AD, Bachert C, Borish L, Chinchilli VM, Danzig MR, Ferguson BJ, Fokkens WJ, Jenkins SG, Lund VJ, Mafee MF, Naclerio RM, Pawankar R, Ponikau JU, Schubert MS, Slavin RG, Stewart MG, Togias A, Wald ER, Winther B (2006) Rhinosinusitis Initiative. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol. 118(5 Suppl):S17-61. https:\/\/doi.org\/10.1016\/j.jaci.2006.09.005. PMID: 17084217","DOI":"10.1016\/j.jaci.2006.09.005"},{"key":"8888_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/000348949510410s02","volume":"167","author":"VJ Lund","year":"1995","unstructured":"Lund VJ, Kennedy DW (1995) Quantification for staging sinusitis. The staging and Therapy Group. Ann Otol Rhinol Laryngol Suppl 167:17\u201321 PMID: 7574265","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"issue":"3","key":"8888_CR17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00405-018-5248-1","volume":"276","author":"A Oleszkiewicz","year":"2019","unstructured":"Oleszkiewicz A, Schriever VA, Croy I, H\u00e4hner A, Hummel T (2019) Updated Sniffin\u2019 sticks normative data based on an extended sample of 9139 subjects. Eur Arch Otorhinolaryngol 276(3):719\u2013728. https:\/\/doi.org\/10.1007\/s00405-018-5248-1. Epub 2018 Dec 15. PMID: 30554358; PMCID: PMC6411676","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"8888_CR18","unstructured":"Lund VJ, Mackay IS (1993) Staging in rhinosinusitis. Rhinology. 31(4):183-184. PMID: 8140385"},{"key":"8888_CR19","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jcf.2022.03.002","volume":"21","author":"AL Stapleton","year":"2022","unstructured":"Stapleton AL et al (2022) Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis. J Cyst Fibros off J Eur Cyst Fibros Soc 21:792\u2013799","journal-title":"J Cyst Fibros off J Eur Cyst Fibros Soc"},{"key":"8888_CR20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1164\/rccm.202308-1317OC","volume":"208","author":"P McNally","year":"2023","unstructured":"McNally P et al (2023) Improvement in lung clearance index and chest computed tomography scores with Elexacaftor\/Tezacaftor\/Ivacaftor Treatment in people with cystic fibrosis aged 12 years and older - the RECOVER Trial. Am J Respir Crit Care Med 208:917\u2013929","journal-title":"Am J Respir Crit Care Med"},{"key":"8888_CR21","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/alr.23288","volume":"14","author":"AC Zemke","year":"2024","unstructured":"Zemke AC et al (2024) Elexacaftor-Tezacaftor-Ivacaftor decreases pseudomonas abundance in the sinonasal microbiome in cystic fibrosis. Int Forum Allergy Rhinol 14:928\u2013938","journal-title":"Int Forum Allergy Rhinol"},{"key":"8888_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1513\/AnnalsATS.202101-057OC","volume":"19","author":"DM Beswick","year":"2022","unstructured":"Beswick DM et al (2022) Impact of cystic fibrosis transmembrane Conductance Regulator Therapy on Chronic Rhinosinusitis and Health Status: deep learning CT analysis and patient-reported outcomes. Ann Am Thorac Soc 19:12\u201319","journal-title":"Ann Am Thorac Soc"},{"key":"8888_CR23","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1002\/lary.30642","volume":"133","author":"S Uyttebroek","year":"2023","unstructured":"Uyttebroek S, Dupont L, Jorissen M, Van Gerven L (2023) Upper Airway Disease in adults with cystic fibrosis in the era of CFTR modulators. Laryngoscope 133:2898\u20132909","journal-title":"Laryngoscope"},{"key":"8888_CR24","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1001\/jamaoto.2023.2701","volume":"149","author":"S Sheikh","year":"2023","unstructured":"Sheikh S et al (2023) Elexacaftor-Tezacaftor-Ivacaftor therapy for chronic sinus disease in cystic fibrosis. JAMA Otolaryngol - Head Neck Surg 149:1075\u20131082","journal-title":"JAMA Otolaryngol -Head Neck Surg"},{"key":"8888_CR25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jcf.2020.07.002","volume":"20","author":"E DiMango","year":"2021","unstructured":"DiMango E et al (2021) Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis. J Cyst Fibros off J Eur Cyst Fibros Soc 20:460\u2013463","journal-title":"J Cyst Fibros off J Eur Cyst Fibros Soc"},{"key":"8888_CR26","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin23.487","author":"S Uyttebroek","year":"2024","unstructured":"Uyttebroek S, Claeyssens C, Jorissen M, Dupont L, Van Gerven L (2024) Dual and triple modulator therapy for chronic rhinosinusitis in cystic fibrosis patients. Rhinology. https:\/\/doi.org\/10.4193\/Rhin23.487","journal-title":"Rhinology"},{"key":"8888_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/1945892419839260","volume":"33","author":"MS Lazio","year":"2019","unstructured":"Lazio MS et al (2019) Quality of life and impact of endoscopic sinus surgery in adult patients with cystic fibrosis. Am J Rhinol Allergy 33:413\u2013419","journal-title":"Am J Rhinol Allergy"},{"key":"8888_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-024-08725-7","author":"M Reale","year":"2024","unstructured":"Reale M et al (2024) Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature. Eur Arch Oto-Rhino-Laryngol. Off J Eur Fed. Oto-Rhino-Laryngol Soc. EUFOS Affil Ger Soc. Oto-Rhino-Laryngol. Head Neck Surg. https:\/\/doi.org\/10.1007\/00405-024-08725-7","journal-title":"- Head Neck Surg"},{"key":"8888_CR29","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1016\/j.jcf.2021.09.014","volume":"21","author":"DM Beswick","year":"2022","unstructured":"Beswick DM et al (2022) Olfactory dysfunction in cystic fibrosis: impact of CFTR modulator therapy. J Cyst Fibros off J Eur Cyst Fibros Soc 21:e141\u2013e147","journal-title":"J Cyst Fibros off J Eur Cyst Fibros Soc"},{"key":"8888_CR30","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1002\/lary.31447","volume":"134","author":"JE Miller","year":"2024","unstructured":"Miller JE et al (2024) Two-year impact of highly effective modulator therapy on olfactory dysfunction. Laryngoscope 134:2492\u20132494","journal-title":"Laryngoscope"},{"key":"8888_CR31","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0031-9384(84)90269-5","volume":"32","author":"RL Doty","year":"1984","unstructured":"Doty RL, Shaman P, Dann M (1984) Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 32:489\u2013502","journal-title":"Physiol Behav"},{"key":"8888_CR32","first-page":"237","volume":"264","author":"T Hummel","year":"2007","unstructured":"Hummel T, Kobal G, Gudziol H, Mackay-Sim A (2007) Normative data for the \u2018Sniffin\u2019 sticks\u2019 including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur. Arch. Oto-Rhino-Laryngol. Off. J. Eur. Fed. Oto-Rhino-Laryngol. Soc. EUFOS Affil. Ger. Soc. Oto-Rhino-Laryngol. - Head Neck Surg 264:237\u2013243","journal-title":"- Head Neck Surg"},{"key":"8888_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.parkreldis.2016.09.023","volume":"33","author":"M Lawton","year":"2016","unstructured":"Lawton M et al (2016) Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin\u2019 sticks test in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 33:96\u2013101","journal-title":"Parkinsonism Relat Disord"},{"key":"8888_CR34","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/lary.30983","volume":"134","author":"M Alicandri-Ciufelli","year":"2024","unstructured":"Alicandri-Ciufelli M et al (2024) Influence of prior endoscopic sinus surgery extent on Dupilumab Effectiveness in CRSwNP patients. Laryngoscope 134:1556\u20131563","journal-title":"Laryngoscope"},{"key":"8888_CR35","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","volume":"397","author":"M Shteinberg","year":"2021","unstructured":"Shteinberg M, Haq IJ, Polineni D, Davies JC (2021) Cystic fibrosis. Lancet Lond Engl 397:2195\u20132211","journal-title":"Lancet Lond Engl"},{"key":"8888_CR36","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.3390\/cells10113260","volume":"10","author":"CMP Ribeiro","year":"2021","unstructured":"Ribeiro CMP, Gentzsch M (2021) Impact of Airway Inflammation on the efficacy of CFTR modulators. Cells 10:3260","journal-title":"Cells"},{"key":"8888_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcf.2023.10.010","volume":"23","author":"SH Donaldson","year":"2024","unstructured":"Donaldson SH et al (2024) Effect of elexacaftor\/tezacaftor\/ivacaftor on mucus and mucociliary clearance in cystic fibrosis. J Cyst Fibros off J Eur Cyst Fibros Soc 23:155\u2013160","journal-title":"J Cyst Fibros off J Eur Cyst Fibros Soc"},{"key":"8888_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.otc.2022.09.009","volume":"56","author":"D-Y Cho","year":"2023","unstructured":"Cho D-Y, Grayson JW, Woodworth BA (2023) Unified airway-cystic fibrosis. Otolaryngol Clin North Am 56:125\u2013136","journal-title":"Otolaryngol Clin North Am"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08888-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-024-08888-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08888-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T15:03:10Z","timestamp":1731596590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-024-08888-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["8888"],"URL":"https:\/\/doi.org\/10.1007\/s00405-024-08888-3","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no financial, organizational, or other relationships that could be interpreted as a conflict of interest relevant to this manuscript. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}